Trial Profile
A multiple-dose pharmacokinetic interaction study between ABT-335 [choline fenofibrate], atorvastatin and ezetimibe.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2010
Price :
$35
*
At a glance
- Drugs Choline fenofibrate (Primary) ; Atorvastatin; Ezetimibe
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Abbott Laboratories
- 04 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2008 New trial record.